These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3310962)

  • 1. A prospective study on the use of monoclonal anti-T3-cell antibody (OKT3) to treat steroid-resistant liver transplant rejection.
    Colonna JO; Goldstein LI; Brems JJ; Vargas JH; Brill JE; Berquist WJ; Hiatt JR; Busuttil RW
    Arch Surg; 1987 Oct; 122(10):1120-3. PubMed ID: 3310962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monoclonal antibody OKT3 therapy in pediatric kidney transplant recipients.
    Leone MR; Barry JM; Alexander SR; Melvin T; Striegel J; Reller K; Henell KR; Kimball J; Funnell MB; Goldstein G
    J Pediatr; 1990 May; 116(5):S86-91. PubMed ID: 2139465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.
    Cosimi AB; Cho SI; Delmonico FL; Kaplan MM; Rohrer RJ; Jenkins RL
    Transplantation; 1987 Jan; 43(1):91-5. PubMed ID: 3099442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of OKT3 monoclonal antibody and anti-thymocyte globulin in the treatment of steroid-resistant acute allograft rejection in pediatric renal transplants.
    Mochon M; Kaiser B; Palmer JA; Polinsky M; Flynn JT; Caputo GC; Baluarte HJ
    Pediatr Nephrol; 1993 Jun; 7(3):259-62. PubMed ID: 8518094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OKT3 monoclonal antibody reversal of renal and hepatic rejection in pediatric patients.
    Goldstein G; Kremer AB; Barnes L; Hirsch RL
    J Pediatr; 1987 Dec; 111(6 Pt 2):1046-50. PubMed ID: 3316579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prophylactic therapy for rejection after cardiac transplantation. A comparison of rabbit antithymocyte globulin and OKT3.
    Kirklin JK; Bourge RC; White-Williams C; Naftel DC; Thomas FT; Thomas JM; Phillips MG
    J Thorac Cardiovasc Surg; 1990 Apr; 99(4):716-24. PubMed ID: 2108282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The treatment of advanced cardiac allograft rejection.
    Sweeney MS; Macris MP; Frazier OH; Sinnott JT; Peric M; McAllister HA
    Ann Thorac Surg; 1988 Oct; 46(4):378-81. PubMed ID: 3140749
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of OKT3 monoclonal antibody in the treatment of acute cardiac allograft rejection.
    Klein JB; McLeish KR; Bunke CM; Chang B; Ganzel BL; Slater AD; Gray LA
    Transplantation; 1988 Apr; 45(4):727-9. PubMed ID: 3282354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infection and rejection of primary hepatic transplant in 93 consecutive patients treated with triple immunosuppressive therapy.
    Ascher NL; Stock PG; Bumgardner GL; Payne WD; Najarian JS
    Surg Gynecol Obstet; 1988 Dec; 167(6):474-84. PubMed ID: 3055368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term follow-up of heart transplant recipients treated with murine antihuman mature T cell monoclonal antibody (OKT3): the Loyola experience.
    Costanzo-Nordin MR; O'Sullivan EJ; Hubbell EA; Zucker MJ; Pifarre R; McManus BM; Winters GL; Scanlon PJ; Robinson JA
    J Heart Transplant; 1989; 8(4):288-95. PubMed ID: 2504895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OKT3 in the reversal of acute hepatic allograft rejection.
    Esquivel CO; Fung JJ; Markus B; Iwatsuki S; Gordon RD; Makowka L; Marsh JW; Tzakis AG; Todo S; Starzl TE
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2443-6. PubMed ID: 3103297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroid-resistant acute rejections after liver transplant.
    Aydogan C; Sevmis S; Aktas S; Karakayali H; Demirhan B; Haberal M
    Exp Clin Transplant; 2010 Jun; 8(2):172-7. PubMed ID: 20565375
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial monitoring of T-cell subset ratios with monoclonal antibodies in steroid- and antithymocyte globulin-treated patients with renal allotransplants.
    Lewis RE; Kirchner K; Preuss T; Raju S; Krueger R; Cuchens M; Bower JD; Cruse JM
    Clin Immunol Immunopathol; 1984 May; 31(2):241-53. PubMed ID: 6232027
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OKT3 monoclonal antibody in pediatric kidney transplant recipients with recurrent and resistant allograft rejection.
    Leone MR; Alexander SR; Barry JM; Henell K; Funnell MB; Goldstein G; Norman DJ
    J Pediatr; 1987 Jul; 111(1):45-50. PubMed ID: 3298596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective randomized trial of OKT3- versus horse antithymocyte globulin-based immunosuppressive prophylaxis in heart transplantation.
    Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Winters GL; Pifarre R; Radvany R; Zucker MJ; Scanlon PJ; Robinson JA
    J Heart Transplant; 1990; 9(3 Pt 2):306-15. PubMed ID: 2113094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
    Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
    J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of refractory cardiac allograft rejection with OKT3 monoclonal antibody.
    Gilbert EM; Dewitt CW; Eiswirth CC; Renlund DG; Menlove RL; Freedman LA; Herrick CM; Gay WA; Bristow MR
    Am J Med; 1987 Feb; 82(2):202-6. PubMed ID: 3544838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3.
    Renlund DG; O'Connell JB; Gilbert EM; Hammond ME; Burton NA; Jones KW; Karwande SV; Doty DB; Menlove RL; Herrick CM
    Transplantation; 1989 Apr; 47(4):599-605. PubMed ID: 2523099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delayed response to orthoclone OKT3 treatment for renal allograft rejection resistant to steroid and antilymphocyte globulin.
    Oh CS; Sollinger HW; Stratta RJ; Kalayoglu M; Belzer FO
    Transplantation; 1988 Jan; 45(1):65-7. PubMed ID: 3276065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized controlled trial of a monoclonal antibody against the interleukin-2 receptor (33B3.1) as compared with rabbit antithymocyte globulin for prophylaxis against rejection of renal allografts.
    Soulillou JP; Cantarovich D; Le Mauff B; Giral M; Robillard N; Hourmant M; Hirn M; Jacques Y
    N Engl J Med; 1990 Apr; 322(17):1175-82. PubMed ID: 2157982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.